GLCE Antikörper (AA 29-617)
Kurzübersicht für GLCE Antikörper (AA 29-617) (ABIN7149462)
Target
Alle GLCE Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 29-617
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human D-glucuronyl C5-epimerase protein (29-617AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- GLCE (Glucuronic Acid Epimerase (GLCE))
-
Andere Bezeichnung
- GLCE
-
Hintergrund
-
Background: Converts D-glucuronic acid residues adjacent to N-sulfate sugar residues to L-iduronic acid residues, both in maturing heparan sulfate (HS) and heparin chains. This is important for further modifications that determine the specificity of interactions between these glycosaminoglycans and proteins.
Aliases: GLCE antibody, KIAA0836 antibody, D-glucuronyl C5-epimerase antibody, EC 5.1.3.17 antibody, Heparan sulfate C5-epimerase antibody, Hsepi antibody, Heparin/heparan sulfate:glucuronic acid C5-epimerase antibody, Heparosan-N-sulfate-glucuronate 5-epimerase antibody
-
UniProt
- O94923
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-